Journal of Gynecologic Oncology

Korean Society of Gynecologic Oncology (대한부인종양학회)
권호 표지
DOI QR코드

DOI QR Code

Survival outcome of women with synchronous cancers of endometrium and ovary: a 10 year retrospective cohort study

  • Lim, Yong-Kuei (Department of Gynaecological Oncology, KK Women's & Children's Hospital) ;
  • Padma, Rama (Department of Gynaecological Oncology, KK Women's & Children's Hospital) ;
  • Foo, Lilian (Duke-NUS Graduate Medical School) ;
  • Chia, Yin-Nin (Department of Gynaecological Oncology, KK Women's & Children's Hospital) ;
  • Yam, Philip (Department of Gynaecological Oncology, KK Women's & Children's Hospital) ;
  • Chia, John (Department of Medical Oncology, National Cancer Centre) ;
  • HS, Khoo-Tan (Department of Medical Oncology, National Cancer Centre) ;
  • Yap, Swee-Peng (Department of Medical Oncology, National Cancer Centre) ;
  • Yeo, Richard (Department of Medical Oncology, National Cancer Centre)
  • Published : 2011.12.01
⟨ Previous Next ⟩

Abstract

Objective: Synchronous occurrence of endometrial and ovarian tumors is uncommon, and they affect less than 10% of women with endometrial or ovarian cancers. The aim of this study is to describe the epidemiological and clinical factors; and survival outcomes of women with these cancers. Methods: This is a retrospective cohort study in a large tertiary institution in Singapore. The sample consists of women with endometrial and epithelial ovarian cancers followed up over a period of 10 years from 2000 to 2009. The epidemiological and clinical factors include age at diagnosis, histology types, grade and stage of disease. Results: A total of 75 patients with synchronous ovarian and endometrial cancers were identified. However, only 46 patients met the inclusion criteria. The median follow-up was 74 months. The incidence rate for synchronous cancer is 8.7% of all epithelial ovarian cancers and 4.9% of all endometrial cancers diagnosed over this time frame. Mean age at diagnosis was 47.3 years old. The most common presenting symptom was abnormal uterine bleeding (36.9%) and 73.9% had endometrioid histology for both endometrial and ovarian cancers. The majority of the women (78%) presented were at early stages of 1 and 2. There were 6 (13.6%) cases of recurrence and the 5 year cumulative survival rate was at 84%. Conclusion: In our cohort, we found that majority of women afflicted with synchronous cancer of the endometrium and ovary were younger at age of diagnosis, had early stage of cancer and good survival.

Keywords

References

  1. Zaino R, Whitney C, Brady MF, DeGeest K, Burger RA, Buller RE. Simultaneously detected endometrial and ovarian carcinomas: a prospective clinicopathologic study of 74 cases: a gynecologic oncology group study. Gynecol Oncol 2001; 83:355-62. https://doi.org/10.1006/gyno.2001.6400
  2. Woodruff JD, Solomon D, Sullivant H. Multifocal disease in the upper genital canal. Obstet Gynecol 1985;65:695-8.
  3. Eisner RF, Nieberg RK, Berek JS. Synchronous primary neoplasms of the female reproductive tract. Gynecol Oncol 1989;33:335-9. https://doi.org/10.1016/0090-8258(89)90523-4
  4. Scully RE, Young RH, Clement PB. Tumors of the ovary, maldeveloped gonads, fallopian tube and broad ligament. Atlas of tumor pathology. Bethesda, MD: Washington Armed Forces Institute of Pathology; 1998.
  5. Soliman PT, Slomovitz BM, Broaddus RR, Sun CC, Oh JC, Eifel PJ, et al. Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases. Gynecol Oncol 2004;94:456-62. https://doi.org/10.1016/j.ygyno.2004.05.006
  6. Caldarella A, Crocetti E, Taddei GL, Paci E. Coexisting endometrial and ovarian carcinomas: a retrospective clinicopathological study. Pathol Res Pract 2008;204:643-8. https://doi.org/10.1016/j.prp.2008.02.001
  7. Gemer O, Bergman M, Segal S. Ovarian metastasis in women with clinical stage I endometrial carcinoma. Acta Obstet Gynecol Scand 2004;83:208-10. https://doi.org/10.1111/j.0001-6349.2004.00408.x
  8. Ulbright TM, Roth LM. Metastatic and independent cancers of the endometrium and ovary: a clinicopathologic study of 34 cases. Hum Pathol 1985;16:28-34. https://doi.org/10.1016/S0046-8177(85)80210-0
  9. Shenson DL, Gallion HH, Powell DE, Pieretti M. Loss of heterozygosity and genomic instability in synchronous endometrioid tumors of the ovary and endometrium. Cancer 1995;76:650-7. https://doi.org/10.1002/1097-0142(19950815)76:4<650::AID-CNCR2820760417>3.0.CO;2-1
  10. Fujita M, Enomoto T, Wada H, Inoue M, Okudaira Y, Shroyer KR. Application of clonal analysis. Differential diagnosis for synchronous primary ovarian and endometrial cancers and metastatic cancer. Am J Clin Pathol 1996;105:350-9. https://doi.org/10.1093/ajcp/105.3.350
  11. Lin WM, Forgacs E, Warshal DP, Yeh IT, Martin JS, Ashfaq R, et al. Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas. Clin Cancer Res 1998;4:2577-83.
  12. Ricci R, Komminoth P, Bannwart F, Torhorst J, Wight E, Heitz PU, et al. PTEN as a molecular marker to distinguish metastatic from primary synchronous endometrioid carcinomas of the ovary and uterus. Diagn Mol Pathol 2003;12:71-8. https://doi.org/10.1097/00019606-200306000-00002
  13. Moreno-Bueno G, Gamallo C, Perez-Gallego L, de Mora JC, Suarez A, Palacios J. Beta-Catenin expression pattern, betacatenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas. Diagn Mol Pathol 2001;10:116-22. https://doi.org/10.1097/00019606-200106000-00008
  14. Kaneki E, Oda Y, Ohishi Y, Tamiya S, Oda S, Hirakawa T, et al. Frequent microsatellite instability in synchronous ovarian and endometrial adenocarcinoma and its usefulness for differential diagnosis. Hum Pathol 2004;35:1484-93. https://doi.org/10.1016/j.humpath.2004.08.011
  15. Shannon C, Kirk J, Barnetson R, Evans J, Schnitzler M, Quinn M, et al. Incidence of microsatellite instability in synchronous tumors of the ovary and endometrium. Clin Cancer Res 2003; 9:1387-92.
  16. Dubeau L. The cell of origin of ovarian epithelial tumours. Lancet Oncol 2008;9:1191-7. https://doi.org/10.1016/S1470-2045(08)70308-5
  17. Eifel P, Hendrickson M, Ross J, Ballon S, Martinez A, Kempson R. Simultaneous presentation of carcinoma involving the ovary and the uterine corpus. Cancer 1982;50:163-70. https://doi.org/10.1002/1097-0142(19820701)50:1<163::AID-CNCR2820500131>3.0.CO;2-K
  18. Chiang YC, Chen CA, Huang CY, Hsieh CY, Cheng WF. Synchronous primary cancers of the endometrium and ovary. Int J Gynecol Cancer 2008;18:159-64. https://doi.org/10.1111/j.1525-1438.2007.00975.x

Cited by

  1. Synchronous primary corpus and ovarian cancer: High incidence of endometriosis and thrombosis vol.4, pp.3, 2011, https://doi.org/10.3892/ol.2012.770
  2. Hereditary portion as an initial genetic approach in gynecologic cancer: synchronous tumor of ovary and endometrium vol.23, pp.1, 2011, https://doi.org/10.3802/jgo.2012.23.1.72
  3. Synchronous primary ovarian and endometrial cancers: a series of cases and a review of literature vol.13, pp.1, 2011, https://doi.org/10.5114/pm.2014.41084
  4. Synchronous Primary Endometrial and Ovarian Cancers: A Multicenter Review of 63 Cases vol.102, pp.5, 2016, https://doi.org/10.5301/tj.5000378
  5. Other Gynecologic Pathology in Endometrial Cancer Patients vol.17, pp.2, 2016, https://doi.org/10.7314/apjcp.2016.17.2.713
  6. Massively Parallel Sequencing-Based Clonality Analysis of Synchronous Endometrioid Endometrial and Ovarian Carcinomas vol.108, pp.6, 2011, https://doi.org/10.1093/jnci/djv427
  7. Elucidating the pathogenesis of synchronous and metachronous tumors in a woman with endometrioid carcinomas using a whole-exome sequencing approach vol.3, pp.6, 2017, https://doi.org/10.1101/mcs.a001693
  8. Guidelines to Aid in the Distinction of Endometrial and Endocervical Carcinomas, and the Distinction of Independent Primary Carcinomas of the Endometrium and Adnexa From Metastatic Spread Between Thes vol.38, pp.1, 2011, https://doi.org/10.1097/pgp.0000000000000553
  9. Prognostic factors of synchronous endometrial and ovarian endometrioid carcinoma vol.30, pp.1, 2011, https://doi.org/10.3802/jgo.2019.30.e7
  10. Risk-based stratification of carcinomas concurrently involving the endometrium and ovary vol.152, pp.1, 2011, https://doi.org/10.1016/j.ygyno.2018.10.033
  11. Synchronous endometrioid endometrial and ovarian carcinomas are biologically related: A clinico-pathological and molecular (next generation sequencing) study of 22 cases vol.17, pp.2, 2011, https://doi.org/10.3892/ol.2018.9855
  12. Clonal relationship and directionality of progression of synchronous endometrial and ovarian carcinomas in patients with DNA mismatch repair-deficiency associated syndromes vol.34, pp.5, 2011, https://doi.org/10.1038/s41379-020-00721-6